Pharmacoeconomic analysis of combination of medicines daclatasvir and asunaprevir in treatment of chronic hepatitis C in the Russian Federation

Autor:	V.V. Babiy, A.Yu. Kulikov, I.V. Shestakova
Rok vydání:	2016
Předmět:	medicine.medical_specialty chemistry.chemical_compound Daclatasvir chemistry Chronic hepatitis business.industry Internal medicine medicine Asunaprevir Russian federation business medicine.drug
Zdroj:	Pharmacoeconomics: theory and practice. 4:131-138
ISSN:	2312-2862
DOI:	10.30809/phe.1.2016.27
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cab58062c583d0e95e37006c6cd4f6e7 https://doi.org/10.30809/phe.1.2016.27 Zobrazit plný text záznamu